Verve Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $650k | 47k | 13.94 |
| 2023-09-30 | $618k | 47k | 13.26 |
| 2023-06-30 | $325k | 23k | 14.42 |
| 2023-03-31 | $325k | 23k | 14.42 |
| 2022-12-31 | $413k | 21k | 19.35 |
| 2022-09-30 | $945k | 28k | 34.35 |
| 2022-06-30 | $229k | 15k | 15.28 |
| 2021-12-31 | $299k | 8.1k | 36.87 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas